Exploring the structural origins of cryptic sites on proteins
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Significance: Cryptic binding sites are absent or occluded in unbound proteins but present in ligand-bound structures. They can provide druggable pockets in cases where the main functional site of the protein cannot be targeted with sufficient potency or specificity. We show that unbound structures of proteins with cryptic sites have strong binding hot spots and above-average flexibility around the incipient pockets. Binding hot spots can be easily identified computationally, and protein flexibility can often be assessed by the analysis of X-ray structures of the unbound protein, including structures with low resolution. The approach presented here helps to assess the potential druggability of cryptic sites prior to running expensive screening experiments and reveals information about how cryptic sites form.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305 · cited 1×
“Many biologically relevant drug targets lack appropriately sized pockets in their unbound structures to support the strong binding of drug-sized ligands (3, 7).”
BackgroundUnraveling hot spots in binding interfaces: progress and challenges
DeLano, W. L. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00283-x · Cited by 767 · cited 3×
“After removing residues 283 to 299 from 1SUG, mapping the truncated protein yielded a strong hot spot, CS1 (17), which overlaps with an inhibitor that binds in this cryptic site, superimposed from the structure 1T48 (46) (Fig.”
BackgroundMaurer, T., Garrenton, L. S., Oh, A., Pitts, K., Anderson, D. J., Skelton, N. J., Fauber, B. P., Pan, B., Malek, S., Stokoe, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116510109 · Cited by 618 · cited 2×
“However, since the site is created by moving only two side chains rather than a longer loop, based on the analysis presented in the previous section, we can predict that it will have only moderate affinity, and this is confirmed by the difficulty of developing drug candidates that bind at this location (43, 44).”
BackgroundDiscovery of Small Molecules that Bind to K‐Ras and Inhibit Sos‐Mediated Activation
Sun, Q., Burke, J. P., Phan, J., Burns, M. C., Olejniczak, E. T., Waterson, A. G., Lee, T., Rossanese, O. W., & Fesik, S. W. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201358 · Cited by 490 · cited 3×
“Our third example is KRAS, an extremely important cancer drug target (42, 43).”
BackgroundTethering: Fragment-Based Drug Discovery
Erlanson, D. A., Wells, J. A., & Braisted, A. C. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.140409 · Cited by 385 · cited 1×
“Experimental identification of cryptic sites generally involves screening libraries of small molecules or fragments (9, 11), site-directed tethering (9, 12), or the use of antibodies (13).”
BackgroundBowman, G. R., & Geissler, P. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209309109 · Cited by 279 · cited 11×
“For example, for IL-2 Beglov et al. PNAS | vol. 115 | no. 15 | E3417 BI O PH YS IC S A N D CO M PU TA TI O N A L BI O LO G Y PN A S PL U S and β-lactamase, Bowman and Geissler (3) reported over 50 pockets that were open and most likely accessible more than 10% of the time.”
BackgroundResultInfluentialArkin, M. R., & Whitty, A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.05.125 · Cited by 190
Self-citationGolden, M. S., Cote, S. M., Sayeg, M., Zerbe, B. S., Villar, E. A., Beglov, D., Sazinsky, S. L., Georgiadis, R. M., Vajda, S., Kozakov, D., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja400914z · Cited by 47
Self-citation
Cited by
Allostery in Its Many Disguises: From Theory to Applications
Wodak, S. J., Paci, E., Dokholyan, N. V., Berezovsky, I. N., Horovitz, A., Li, J., Hilser, V. J., Bahar, I., Karanicolas, J., Stock, G., et al. (2019) · Structure · doi:10.1016/j.str.2019.01.003 · Cited by 404
“The authors also reported that regions of protein structures close to cryptic binding sites are significantly more flexible than regions surrounding any other potential binding hotspots detected by their procedure (Beglov et al., 2018).”
BackgroundSelf-citationLazim, R., Suh, D., & Choi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176339 · Cited by 185
“org), formulated a similar protocol, which engages benzene probes to facilitate the identification of cryptic pockets [91,101,102].”
BackgroundCryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs
Hollingsworth, S. A., Kelly, B., Valant, C., Michaelis, J. A., Mastromihalis, O., Thompson, G., Venkatakrishnan, A. J., Hertig, S., Scammells, P. J., Sexton, P. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11062-7 · Cited by 73
Verkhivker, G. M., Agajanian, S., Hu, G., & Tao, P. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00136 · Cited by 76
Hirano, Y., Okimoto, N., Fujita, S., & Taiji, M. (2021) · ACS Omega · doi:10.1021/acsomega.1c02159 · Cited by 31
Metadata
- Authors
- Beglov, D., Hall, D. R., Wakefield, A. E., Luo, L., Allen, K. N., Kozakov, D., Whitty, A., & Vajda, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2018-03-26
- Volume
- 115
- Issue
- 15
- Pages
- E3416-E3425
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2791506886
- Cited by
- 134
- References
- 8
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exploring the structural origins of cryptic sites on proteins. https://app.cochat.ai/papers/10.1073/pnas.1711490115
- The paper
- Beglov, D., Hall, D. R., Wakefield, A. E., Luo, L., Allen, K. N., Kozakov, D., Whitty, A., & Vajda, S. (2018). Exploring the structural origins of cryptic sites on proteins. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1711490115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.